Skip to main content
. 2023 Mar 27;14(5):759–769. doi: 10.7150/jca.82410

Table 2.

Pharmacokinetic parameters of NPs and Taxol® (Compared to Taxol®, ***P<0.001; n=6)

Taxol® PTX PLGA NPs PTX PLGA/CD NPs
t1/2α(h) 0.32±0.10 0.20±0.03 0.27±0.02
t1/2β(h) 1.43±1.34 2.75±1.43 9.23±3.58***
MRT0-t(h) 1.74±0.61 1.14±0.42 2.31±0.18
MRT0-∞(h) 2.29±0.46 9.42±14.01 23.48±25.19***
AUC0-t(ng·L-1·h) 5539.36±1859.73 6030.09±541.22 10152.88±1470.54***
AUC0-∞(ng·L-1·h) 6383.63±3022.91 7092.40±1520.21 16466.73±5189.89***
Cmax(ng·L-1) 5828.35±170.70 10639.20±408.68*** 12494.06±2664.56***
CL(L·h-1·kg) 4.31±0.08 2.90±0.53 1.30±0.33